{
  "title": "Behind The Idea #98: Varian's Moat May Be Worth The Price",
  "description": "We continue our special November series. Mike shares his long thesis for Varian Medical Systems, an industry leader in oncology treatment devices that has a lot of attractive business aspects, though it's valuation is also challenging. Daniel tries to probe the thesis for any gaps, but the moat here seems quite strong.\nTopics Covered\n\n5:00 minute mark - Introduction to Varian Medical Systems and the business case\n\n12:40 - How much does it matter that there are two revenue lines in the income statement? Oncology vs. Proton and Product vs. Service\n\n19:30 - Any reason to think they are transforming more to a service business? \n\n24:30 - Market and customer relationship strategy... moat around business.\n\n31:00 - Is a throughput based model something to be concerned about?\n\n36:00 - Valuation\n\n53:30 - The under the radar aspect of VAR.",
  "pubDate": "Tue, 12 Nov 2019 09:00:00 -0000",
  "itunes:title": "Varian's Moat May Be Worth The Price",
  "itunes:episodeType": "full",
  "itunes:episode": 98,
  "itunes:author": "Seeking Alpha",
  "itunes:subtitle": "Mike takes his turn pitching an idea, highlighting an industry leader with growth prospects",
  "itunes:summary": "We continue our special November series. Mike shares his long thesis for Varian Medical Systems, an industry leader in oncology treatment devices that has a lot of attractive business aspects, though it's valuation is also challenging. Daniel tries to probe the thesis for any gaps, but the moat here seems quite strong.\nTopics Covered\n\n5:00 minute mark - Introduction to Varian Medical Systems and the business case\n\n12:40 - How much does it matter that there are two revenue lines in the income statement? Oncology vs. Proton and Product vs. Service\n\n19:30 - Any reason to think they are transforming more to a service business? \n\n24:30 - Market and customer relationship strategy... moat around business.\n\n31:00 - Is a throughput based model something to be concerned about?\n\n36:00 - Valuation\n\n53:30 - The under the radar aspect of VAR.",
  "content:encoded": "<p>We continue our special November series. Mike shares his long thesis for Varian Medical Systems, an industry leader in oncology treatment devices that has a lot of attractive business aspects, though it's valuation is also challenging. Daniel tries to probe the thesis for any gaps, but the moat here seems quite strong.</p><h1>Topics Covered</h1><ul>\n<li>5:00 minute mark - Introduction to Varian Medical Systems and the business case</li>\n<li>12:40 - How much does it matter that there are two revenue lines in the income statement? Oncology vs. Proton and Product vs. Service</li>\n<li>19:30 - Any reason to think they are transforming more to a service business? </li>\n<li>24:30 - Market and customer relationship strategy... moat around business.</li>\n<li>31:00 - Is a throughput based model something to be concerned about?</li>\n<li>36:00 - Valuation</li>\n<li>53:30 - The under the radar aspect of VAR.</li>\n</ul>",
  "itunes:duration": 3580,
  "itunes:explicit": "no",
  "guid": "5c468bec-0215-11ea-a5fc-fba5a3530172",
  "enclosure": ""
}